RNU6-390P

Across TCGA pan-cancer cohorts, RNU6-390P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated RNU6-390P data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher RNU6-390P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-390P expression acts as an unfavorable survival marker, although some lineages such as ESCA and SKCM show a favorable association.

COAD, ESCA, and STAD are the cancer types where RNU6-390P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	All	0.045	0.871	<.001	72	view →
ESCA	OS	Tertile	III,IV	1.000	0.351	.006	63	view →
STAD	OS	Tertile	IV	0.052	0.541	.003	54	view →
UCEC	OS	Tertile	III,IV	0.053	0.588	.005	36	view →
THYM	OS	Tertile	All	0.775	0.973	.031	9	view →
SKCM	OS	Tertile	All	0.800	0.330	.031	3	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RNU6-390P–COAD (OS)

Open the COAD breakdown →